ArticleMolecular oncology2020

An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer.

Chun-Hao Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.